Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
VIR
VIR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VIR News
Wall Street Analysts Adjust Ratings
6d ago
Benzinga
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Vir Biotechnology Announces Pricing of Public Offering
Feb 26 2026
NASDAQ.COM
Marriott Vacations Reports Strong Q4, Shares Surge
Feb 26 2026
Benzinga
Vir Biotechnology Prices Public Offering at $8.50 per Share
Feb 26 2026
seekingalpha
Vir Biotechnology Prices Public Offering at $8.50 per Share
Feb 26 2026
Businesswire
Vir Biotechnology Prices Public Offering at $8.50 per Share
Feb 26 2026
Newsfilter
Vir Biotechnology Plans $200M Public Offering
Feb 24 2026
seekingalpha
Super Group and Vir Biotechnology Options Show High Trading Volume
Feb 24 2026
NASDAQ.COM
Analysis of Stock Price Movements for Multiple Companies
Feb 24 2026
CNBC
U.S. Stocks Rise with Dow Jones Up Over 400 Points
Feb 24 2026
Benzinga
Kraig Biocraft's Spider Silk Technology Gains Attention
Feb 24 2026
Globenewswire
Kraig Biocraft Laboratories Featured on National Geographic Cover
Feb 24 2026
Newsfilter
Vir Biotechnology Surpasses Expectations with New Therapy Data
Feb 24 2026
stocktwits
Small-Cap Biotech Stock Jumps 26% Amid Enthusiasm for Prostate Cancer Treatment.
Feb 24 2026
Barron's
Vir Biotechnology Secures Multi-Billion Dollar Deal with Astellas
Feb 24 2026
Benzinga
Show More News
